Relief from degenerative spine-related diseases begins here…

Overview

Improving the lives of millions...

Spine BioPharma is committed to bringing to market innovative non-surgical, non-opiate therapies to treat degenerative spine related diseases. Our pipeline of therapeutic treatments target the clinical benefits of reducing pain, restoring function and slowing or stopping pathological disease progression.

Our Mission

Our mission is to improve the lives of millions of individuals suffering every day from degenerative spine diseases by delivering clinically proven, safe, and effective therapies that inhibit pain and inflammation, and restores quality-of-life.

Who We Are

We are a team of solutions-oriented spine-disease experts that have dedicated our lives to making a difference for patients. Through partnerships with pharmaceutical companies, brilliant scientists and compassionate clinicians, we have assembled a portfolio of degenerative spine disease-specific therapeutic solutions that represent potential first-in-class and best-in-class potential treatments for millions of patients.

Our therapeutic solutions are backed by solid science and clinical experience. We look forward to bringing them through the regulatory approval processes to create access for millions of patients suffering from debilitating spinal diseases.

Spine BioPharma’s lead candidate, SB-01

is a first-in-class, therapeutic for the treatment of degenerative disc disease, offering potential clinical benefits of pain relief, restoration of function and potential prevention of disease progression. SB-01 is administered by a physician as an intradiscal injection.

Please learn more about our Phase 3 clinical trial